Skip to content

All published articles 370

Targeting Abnormal Methylation Enzymes: A New Approach to Cancer Therapy

Ming C. Liau, Chrinstine L. Craig & Linda L. Baker · Journal of Cancer and Tumor International · 2025

The objective of this article is to promote abnormal methylation enzymes (MEs) as a critical cause of cancer and the destabilization of abnormal MEs as a new approach to direct cancer therapy. MEs are a ternary enzyme complex consisting methionine adenosyltransferase (MAT)-methyl...

Open access Research Article 10.9734/jcti/2025/v15i2295

BRCA Mutations in Breast Cancer Insights into Genetic Risk and Tailored Therapeutic Interventions

Lawrence John AJutor, Edibokun Theresa Orobator, Blessing Ben- Anioke, Victor Chiedozie Ezeamii, Mayowa Josiah Badmus, Uchechi Ngozichukwu Obiefule, Vincent Barrah, Mary Oluwabunmi Oyebode & Josiah Stephen · Journal of Cancer and Tumor International · 2025

BRCA1 and BRCA2 genes, located on separate chromosomes, encode crucial multifunctional proteins that are important for correcting errors in DNA replication and cell division. The two genes work in tandem at different stages in the DNA damage response and for DNA repair and could...

Open access Research Article 10.9734/jcti/2025/v15i2296

From Bench to Bedside: Medicinal Chemistry Strategies in the Development of Kinase Inhibitors for Cancer Therapy

Chibuike Emmanuel Okafor, Emmanuel Cherechi Egwuatu, Victor Ayoola Owosagba, Teckla Njei, Bankole Israel ADEYEMI, Philip Ugbede Ojo Onuche, Abdullahi Adams, Chiamaka Blessing Ugwuja, Eze Samson Chibueze & Olabisi Promise Lawal · Journal of Cancer and Tumor International · 2025

Cancer, a multifaceted clinical challenge, is driven by dysregulation of protein kinases—key regulators of critical cellular function. The introduction of kinase inhibitors has transformed targeted cancer therapy, ushering in a change from traditional chemotherapy to precision on...

Open access Research Article 10.9734/jcti/2025/v15i2294

The Role of Circulating Tumor DNA in Early Detection of HER2-positive Breast Cancer

Sayed Abulqasem Kazemi, Koshechkin Konstantin, Mohammad Nazeer Masal & Ahmad Ishaq · Journal of Cancer and Tumor International · 2025

Breast cancer remains one of the major global health challenges, the Human Epidermal Receptor-2 (HER-2) subtype is characterized by aggressive tumor growth due to overexpression of the HER2-positive. Early detection of HER2-positive breast cancer is crucial for improving patient’...

Open access Research Article 10.9734/jcti/2025/v15i2293

Managing Cabozantinib-induced Dysgeusia: Mechanisms, Clinical Impact, and Strategies for Improved Oncology Outcomes

Oghenetanure Ryan Enaworu, Monsurat Nasiru, Urmila Palla, Enibokun Theresa Orobator, Moyosore Taiwo, Wuraola Awosan & Ozioma Esther Onuselogu · Journal of Cancer and Tumor International · 2025

Cabozantinib, a potent tyrosine kinase inhibitor (TKI), targets vascular endothelial growth factor receptor (VEGFR), mesenchymal-epithelial transition factor (MET), and AXL receptor tyrosine kinase to inhibit tumour angiogenesis, metastasis, and proliferation in advanced renal ce...

Open access Research Article 10.9734/jcti/2025/v15i2292

Integrated Bioinformatics Analysis of Key Genes Involved in Progression of Papillary and Follicular Thyroid Cancer

Aisha Ibrahim Usman, Dariga Boken, Siqi Liu, Musa Usman Ibrahim, Xiaodan Lu, Jingbin Zhang & Mohammed Sharif Swallah · Journal of Cancer and Tumor International · 2025

Background: Thyroid cancer, the most common endocrine neoplasia, has seen a rapid increase in global incidence, with the USA reporting over 62,000 new cases in 2015, making it the fifth most common cancer among women. Differentiated thyroid cancer accounts for more than 95% of ca...

Open access Research Article 10.9734/jcti/2025/v15i2291

Assessing Knowledge Level of Secondary School Students on Causes, Effects and Prevention of Breast Cancer in Tamale Metropolis, Ghana

Keren-Happuch Twumasiwaa Boateng, Samuel Kwame Amoako Asirifi, Williams Kwame Boateng, Irene Adu Boateng & Alhassan Ruhiya Nagumsi · Journal of Cancer and Tumor International · 2025

Background: The death rate related to breast cancer in Africa is frighteningly high and the prevalence of breast cancer is continuously increasing. The majority of breast cancer cases that are diagnosed and treated quickly can be cured. However, in some cases, acquired resistance...

Open access Research Article 10.9734/jcti/2025/v15i2290

Leptomeningeal Metastasis: Current Treatment, and Emerging Therapies

Zain Jandial, Rachana Garg, Ashvin Kumar & Mike Chen · Journal of Cancer and Tumor International · 2025

Leptomeningeal carcinomatosis (LC) is a rare but devastating manifestation of cancer that has undergone metastatic spread to the cerebrospinal fluid and leptomeninges. The most common malignancies associated with LC are melanoma, breast, and lung cancers. LC severely influences m...

Open access Research Article 10.9734/jcti/2025/v15i2289

The Role of Cancer-associated Fibroblasts in the Microenvironment of Invasive Ductal Carcinoma (IDC) Breast Cancer

Habib Olaniran Kolawole, Edibokun Theresa Orobator, Blessing Imade, Victor Damilare Oladele, Ezema Izuchukwu Gerald, Kamsiyochukwu Anita Ezeani, Daniel Ebubechi Obasi, Adegbesan Abiodun Christopher, Peter Bemigho Adewoyin & Lawrence John AJutor · Journal of Cancer and Tumor International · 2025

There has been an increase in the amount of studies focusing on the relevance of tumour microenvironment (TME) in metastasis of breast cancer. Cancer-associated fibroblasts (CAFs) is one of the most abundant cells found in the TME that play key roles in the metastasis of cancers...

Open access Research Article 10.9734/jcti/2025/v15i2288

Balancing Treatment Benefits and Risks of Severe Adverse Effects of Immunotherapy in Cancer: A Systematic Review

Zachrieh Alhaj, Zaid Almubaid, Nada Alhaj, Mohammed Omar Almosa, Abdulkader Almosa & Selma Abdurrahman · Journal of Cancer and Tumor International · 2025

Background: Melanoma has shown resistance to conventional treatments, resulting in poor prognoses. Recent advancements in immunotherapy have improved patient outcomes. However, these therapies are associated with severe adverse reactions, raising concerns about their safety. Meth...

Open access Research Article 10.9734/jcti/2025/v15i1287

Pattern and Epidemiologic Characteristics of Malignant Tumours Seen in Rivers State University Teaching Hospital, Port Harcourt: A Retrospective Study from January 2017 to December 2022

Christian Chika Ogbu, Okezie Chinedu Ugwa & Darlington Chidi Amadi · Journal of Cancer and Tumor International · 2025

Aim: To review malignant tumours seen at Rivers State University Teaching Hospital from January 2017 to December 2022, to assess the gender and age distribution of these tumours and to assess whether there is a correlation between ages of these patients and these malignant tumour...

Open access Research Article 10.9734/jcti/2025/v15i1286

Effect of Rosemary Leaf Ethanol Extract (Rosmarinus officinalis L.) on Arginase-1 and Tumor Suppressor P53 Expression of Hepatocellular Carcinoma in Male Wistar Strain Rats (Rattus norvegicus L.) Induced By p-Dimethylamino benzaldehyde (DMBA)

Dewa Ayu Made Adnyaswari, Agung Wiwiek Indrayani, I Gusti Ayu Artini, Desak Ketut Ernawati, I Gusti Made Gede Surya Candra Trapika, Ni Putu Sriwidyani & I Gusti Kamasan Nyoman Arijana · Journal of Cancer and Tumor International · 2025

Aims: Tumor Suppressor p53 is a frequent research target to further understand the mechanisms of cancer development and the pathogenesis of cancer. Arginase-1 may also be a potential prognosis predictor for HCC patients, and also be a new target for HCC treatment. This research a...

Open access Research Article 10.9734/jcti/2025/v15i1285

Evaluation of Hematological Parameters Pre and Post Chemotherapy in Breast Cancer Patients at the National Cancer Institute in Sudan at Khartoum state, Sudan

Hiba Ahmed Fadlallah Ahmed, Safa Habiballa Mohammed Ahmed, Saja Daffallah Abosara Mohamed, Salma Hashim Awadalkharim Alamain, Shaza Abulgasim Osman Alhaj bakheet, Zohal Kamal Dafallah Shams Aldeen, May Awad Mohammed Ashmeig, Muslih Haroun Elhussein Gamea & Ehab Mohammed Elmadenah Mohammed Ahmed · Journal of Cancer and Tumor International · 2025

Introduction: Breast cancer is the most common malignancy among women worldwide, including in Sudan. Chemotherapy, a primary treatment modality, often results in hematological toxicity, impacting patients' overall health and treatment efficacy. This study aims to evaluate the cha...

Open access Research Article 10.9734/jcti/2025/v15i1284

Giant Keratoacanthoma Centrifugum Marginatum: A Rare Case Report with Note on Literature Review

Stuti Chhawchharia, Amar Singh, Amit Rana & Mamta Verma · Journal of Cancer and Tumor International · 2025

Introduction: Keratoacanthoma Centrifugum Marginatum (KCM) is a rare variant of keratoacanthoma that closely mimics squamous cell carcinoma (SCC), posing significant diagnostic challenges. Case Report: A 45-year-old male presented with a progressively enlarging hyperkeratotic les...

Open access Research Article 10.9734/jcti/2025/v15i1283

Phytochemical and Cytotoxic Evaluation of the Fruits of Rauwolfia vomitoria Afzel. (Apocynaceae)

Mikailu Suleiman & Joy Nkemkanma Iwedi · Journal of Cancer and Tumor International · 2025

Rauwolfia vomitoria fruits has been claimed to be used traditionally in treating cancer related diseases. However, this activity has not yet been scientifically proven. This study focused on investigating the cytotoxicity activity of this plant on Tadpoles (Raniceps raninus). The...

Open access Research Article 10.9734/jcti/2025/v15i1282